Viewing Study NCT04806035


Ignite Creation Date: 2025-12-24 @ 10:06 PM
Ignite Modification Date: 2025-12-28 @ 3:25 PM
Study NCT ID: NCT04806035
Status: TERMINATED
Last Update Posted: 2024-07-31
First Post: 2021-03-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia
Sponsor: TG Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module